Systems Biology Guided Therapy for Breast Cancer Positive for Oestrogen Receptor After Aromatase Inhibitor and CDK Inhibition
Phase: PHASE2
Conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer
Sponsor: Inova Health Care Services

 
Inova.org 
 
 
 
Cover Page 
 
 
 
 
 
Principal Investigator: 
Adam Cohen, MD 
 
Protocol Title: 
Biology Guided Therapy for Breast Cancer Positive for Oestrogen 
Receptor after Aromatase Inhibitor and CDK inhibition (SPOCK) 
 
NCT Number:  
 
NCT04965688 
 
Protocol Version Date: 
August 08, 2022 
 
IRB approval Date:   
September 18, 2022 
 
Protocol Number:  
 
U21-02-4401, WCG IRB Protocol #20212138 
Inova Schar Cancer  
Clinical Trials Office 
8081 Innovation Park Drive 
Fairfax, VA 22031 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org 
 

 
Inova.org